Tjeerd J. Postma

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications

Long-Term Follow-Up Results of Antiseizure Medication Withdrawal in Grade 2 and 3 Glioma Patients: A Prospective Observational Study.

Long-Term Follow-Up Results of Antiseizure Medication Withdrawal in Grade 2 and 3 Glioma Patients: A Prospective Observational Study.

Journal: Neurology
Published: October 23, 2025

Long-Term Follow-Up Results of Antiseizure Medication Withdrawal in Grade 2 and 3 Glioma Patients: A Prospective Observational Study.

Long-Term Follow-Up Results of Antiseizure Medication Withdrawal in Grade 2 and 3 Glioma Patients: A Prospective Observational Study.

Journal: Neurology
Published: April 29, 2025

Frequency and burden of potentially treatable symptoms in glioma patients with stable disease.

Frequency and burden of potentially treatable symptoms in glioma patients with stable disease.

Journal: Heliyon
Published: June 20, 2022

Prospective validation of a new imaging scorecard to assess leptomeningeal metastasis: A joint EORTC BTG and RANO effort.

Prospective validation of a new imaging scorecard to assess leptomeningeal metastasis: A joint EORTC BTG and RANO effort.

Journal: Neuro-oncology
Published: February 14, 2022

A multidisciplinary neuro-oncological triage panel reduces the time to referral and treatment for patients with a brain tumor.

A multidisciplinary neuro-oncological triage panel reduces the time to referral and treatment for patients with a brain tumor.

Journal: Neuro-oncology practice
Published: September 30, 2021

The RANO Leptomeningeal Metastasis Group proposal to assess response to treatment: lack of feasibility and clinical utility and a revised proposal.

The RANO Leptomeningeal Metastasis Group proposal to assess response to treatment: lack of feasibility and clinical utility and a revised proposal.

Journal: Neuro-oncology
Published: February 05, 2019

Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study.

Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study.

Journal: Journal of neuro-oncology
Published: December 05, 2018

Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity.

Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity.

Journal: Journal of the peripheral nervous system : JPNS
Published: September 14, 2018

Visual inspection of MR relative cerebral blood volume maps has limited value for distinguishing progression from pseudoprogression in glioblastoma multiforme patients.

Visual inspection of MR relative cerebral blood volume maps has limited value for distinguishing progression from pseudoprogression in glioblastoma multiforme patients.

Journal: CNS oncology
Published: October 07, 2017

Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20).

Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20).

Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Published: June 13, 2017

Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis.

Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis.

Journal: Journal of neuro-oncology
Published: March 31, 2016

Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide.

Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide.

Journal: Journal of neuro-oncology
Published: June 14, 2015
Showing 1-12 of 37

Last Updated: 09/26/2026